GlaxoSmithKline and Verily Life Sciences £540 million Galvani Bioelectronics joint venture

Overview:

• GlaxoSmithKline and Verily Life Sciences, owned by Google holding company Alphabet, have formed a £540 million joint venture.
• The project will consist of the creation of a new company Galvani Bioelectronics (to be based in Hertfordshire, UK), that will research ways of fighting disease through electronic implants.
• GSK will own 55% of the new company and Verily 45%.

Sam Duke - Editor